Overview
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 66 days late).
- 202530/06/2026
- 202424/06/2025
- 202326/06/2024
- 202223/06/2023
- 202119/09/2022
- 202022/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Premium Pharma has been an NFZ healthcare provider since 2026. In 2026 it is performing 2 contracts with a total value of USD 108.05.
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Pilot programmes | pomorskie | 1 | USD 108.05 |
| Other services provided in pharmacies | pomorskie | 1 | USD 0.00 |
Authorized Representatives
Manner of representation
To represent the company and make declarations of will on its behalf, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 50 | $6,753.11 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-04-01.
21 1050 1764 1000 0092 0981 7064
37 1240 1066 1111 0011 6198 8185
68 1140 2004 0000 3002 7556 2171
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $16,288.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 12, 2026 | Aid for microenterprises in the form of public interventions concerning electricity, gas or heat supplies | $40$40 | Energa - Obrót S.A. | |
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,905$1,905 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,522$1,522 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Gold Lionsp. z o.o. | $1,669,649.21 | goldlion.pl | ||
| Grupa Aptekarska Kujałowiczsp. j. | $1,452,484.91 | wga.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-05 | Address change (Ul. Jaśminowy Stok 19c, 80-177, Gdańsk → Ul. Anny Walentynowicz 8a/8, 71-294, Szczecin) | |
| 2025-11-05 | PKD change (Removed: 46.46.Z, 49.41.Z, 68.20.Z, 82.99.Z, 86.90, 96.09.Z; Added: 21.10.Z, 47.75.Z, 47.78.Z) | |
| 2015-02-27 | Entered in the register |
FAQ
Last updated: 2026-10-04